|
시장보고서
상품코드
1463779
세계의 컨시어지 의료 시장 : 시장 규모 및 점유율 분석 - 용도별(1차의료, 소아과, 정체, 내과, 순환기과, 정신과), 소유 형태별(단독, 집단), 최종사용자별(성인, 소아) : 산업 수요 예측(-2030년)Concierge Medicine Market Size and Share Analysis by Application (Primary Care, Pediatrics, Osteopathy, Internal Medicine, Cardiology, Psychiatry), Ownership (Independent, Group), End User (Adults, Children) - Global Industry Demand Forecast to 2030 |
||||||
시장 개요
세계의 컨시어지 의료 시장 규모는 약 171억 달러입니다. 그러나 이 수치는 2030년까지 276억 달러로 상승할 전망이며, 2024-2030년의 CAGR은 7.3%입니다.
이러한 업계의 발전은 초기 질환 진단에 관한 지식의 증가, 고령자 인구의 증가, 건강하고 균형 잡힌 라이프스타일을 얻기 위한 개인 노력의 증가에 의한 것입니다. 또한 컨시어지 의료가 제공하는 이점은 의사의 고액 보수와 환자의 대기 시간 단축입니다.
주요 인사이트
2023년에는 1차의료(Primary care) 카테고리가 최대 업계 점유율을 차지하고 있습니다. 그 요인으로 환자의 의식이 높아지고, 의사에 대한 즉시 액세스 및 첨단 의료 서비스가 제공되기 때문입니다.
컨시어지 의료는 개별화 대응 의료 서비스와 의료 제공자의 부족에 의해 고소득자 사이에서 인기를 끌고 있습니다.
소아과는 예측 기간 중 CAGR이 7.8%로 가장 높을 것으로 예측됩니다. 이것은 소아과 의사가 개별 환자, 특히 표적 진단과 치료를 필요로 하는 신생아, 유아, 유아를 치료하는 시간이 증가하기 때문입니다.
2023년에는 그룹 카테고리가 약 60%의 점유율로 업계를 지배합니다.
컨시어지 의료에서 단독 경영(개업의)은 예측 기간 중 급속히 진행될 것으로 예측됩니다.
세계의 컨시어지 의료 시장을 분석했으며, 시장의 기본 구조·최신 상황 및 주요 촉진·억제요인, 세계 전체 및 지역별·주요 국가 시장 규모의 동향 전망(금액 기반, 2017-2030년), 용도별·소유 형태별·최종사용자별의 상세 동향, 현재의 시장 경쟁 상황, 주요 기업의 개요 등을 조사하여 전해드립니다.
목차
제1장 조사 범위
제2장 조사 방법
제3장 주요 요약
제4장 시장 지표
제5장 업계의 전망
- 시장 역학
- 동향
- 촉진요인
- 억제요인/과제
- 촉진요인/억제요인의 영향 분석
- 신종 코로나바이러스 감염증(COVID-19)의 영향
- Porter's Five Forces 분석
제6장 세계 시장
- 개요
- 시장 매출 : 용도별(2017-2030년)
- 시장 매출 : 소유 형태별(2017-2030년)
- 시장 매출 : 최종사용자별(2017-2030년)
- 시장 매출 : 지역별(2017-2030년)
제7장 북미 시장
- 개요
- 시장 매출 : 용도별(2017-2030년)
- 시장 매출 : 소유 형태별(2017-2030년)
- 시장 매출 : 최종사용자별(2017-2030년)
- 시장 매출 : 국가별(2017-2030년)
제8장 유럽 시장
제9장 아시아태평양 시장
제10장 라틴아메리카 시장
제11장 중동 및 아프리카 시장
제12장 미국 시장
- 개요
- 시장 매출 : 용도별(2017-2030년)
- 시장 매출 : 소유 구조별(2017-2030년)
- 시장 매출 : 최종사용자별(2017-2030년)
제13장 캐나다 시장
제14장 독일 시장
제15장 프랑스 시장
제16장 영국 시장
제17장 이탈리아 시장
제18장 스페인 시장
제19장 일본 시장
제20장 중국 시장
제21장 인도 시장
제22장 호주 시장
제23장 한국 시장
제24장 브라질 시장
제25장 멕시코 시장
제26장 사우디아라비아 시장
제27장 남아프리카공화국 시장
제28장 아랍에미리트(UAE) 시장
제29장 경쟁 구도
- 시장 참여 기업과 제공 제품/서비스 리스트
- 주요 기업의 경쟁 벤치마킹
- 주요 기업의 제품 벤치마킹
- 최근 전략 개발 상황
제30장 기업 개요
- Campbell Family Medicine
- Castle Connolly Private Health Partners LLC
- CONCIERGE CONSULTANTS & CARDIOLOGY
- MDVIP LLC
- PartnerMD
- PENINSULA DOCTOR
- Priority Physicians Inc.
- SignatureMD Inc.
- Specialdocs Consultants LLC
제31장 부록
KSA 24.05.02Market Overview
The global concierge medicine market is around USD 17.1 billion. However, this figure is estimated to rise to USD 27.6 billion by 2030, which is equivalent to a 7.3% compound annual growth rate from 2024 to 2030.
This development of the industry can be credited to the increasing knowledge about initial disease diagnosis, the growing elderly populace, and the increasing efforts of individuals to attain a healthy and balanced lifestyle. Moreover, the benefits provided by concierge medicine comprise high recompenses for doctors and reduced waiting times for patients, which make this method common among both.
With the increasing use of telemedicine and tele health, the market picked up. Patients who have availed of concierge medicine services appreciate these technologies as they can schedule consultations with the physician as and when convenient. On the other hand, it replaces traveling that a patient would take to the doctor 's office.
This helps save patients time and money. Telemedicine applications provide high-resolution audio and video teleconferences, which enable easy access for patients to the physician from the comfort of their homes.
In addition to that, providers can manage the number of patients not showing up, since telemedicine could be utilized for this purpose. Thus, the convenience offered by such technologies has a positive impact on patient flow and increases the doctor's revenue.
Key Insights
In 2023, the primary care category grips the largest industry share because of augmented patient awareness, offering instant access to doctors and advanced-quality medicinal services.
For the patients the main advantage of primary care is that they receive longer, more comprehensive consultations, and get used to this setting, with the high patient volumes, to keep pace.
Concierge medicine is gaining popularity among high earners due to personalized healthcare services and the shortage of healthcare providers.
Paediatrics is projected to have the highest CAGR rate of 7.8% during the forecast period because pediatricians will have more time to treat each patient, especially neonates, infants, and toddlers who require targeted diagnosis and treatment.
In 2023, the group category dominates the industry with a share of approximately 60%.
The substantial existence of several top firms in the market offering these services is the major factor propelling the market.
Independent ownership in concierge medication is projected to advance quickly over the forecast period.
Independent practitioners see fewer patients every day in comparison to regular and group ownership models, leading to less workload, better compensation, and job satisfaction.
Rising awareness regarding physical well-being and the accuracy of healthcare boosts industry development.
Well-established healthcare infrastructure and favourable medical reimbursement policies contribute significantly to the region's dominance.
The global increase in the range of diseases of duration such as cancer, hyperglycaemia, and obesity is an issue that facilitates the development of precision medicine solutions.
The presence of a significant elderly population drives demand for immediate medical attention, supporting market growth.
The customization healthcare services, come with convenience and personalized care, thus attracting elderly patients and leading to the broadening of the market.
Table of Contents
Chapter 1. Research Scope
- 1.1. Research Objectives
- 1.2. Market Definition
- 1.3. Analysis Period
- 1.4. Market Size Breakdown by Segments
- 1.4.1. Market size breakdown, by application
- 1.4.2. Market size breakdown, by ownership
- 1.4.3. Market size breakdown, by end user
- 1.4.4. Market size breakdown, by region
- 1.4.5. Market size breakdown, by country
- 1.5. Market Data Reporting Unit
- 1.5.1. Value
- 1.6. Key Stakeholders
Chapter 2. Research Methodology
- 2.1. Secondary Research
- 2.1.1. Paid
- 2.1.2. Unpaid
- 2.1.3. P&S Intelligence database
- 2.2. Primary Research
- 2.3. Market Size Estimation
- 2.4. Data Triangulation
- 2.5. Currency Conversion Rates
- 2.6. Assumptions for the Study
- 2.7. Notes and Caveats
Chapter 3. Executive Summary
Chapter 4. Market Indicators
Chapter 5. Industry Outlook
- 5.1. Market Dynamics
- 5.1.1. Trends
- 5.1.2. Drivers
- 5.1.3. Restraints/challenges
- 5.1.4. Impact analysis of drivers/restraints
- 5.2. Impact of COVID-19
- 5.3. Porter's Five Forces Analysis
- 5.3.1. Bargaining power of buyers
- 5.3.2. Bargaining power of suppliers
- 5.3.3. Threat of new entrants
- 5.3.4. Intensity of rivalry
- 5.3.5. Threat of substitutes
Chapter 6. Global Market
- 6.1. Overview
- 6.2. Market Revenue, by Application (2017-2030)
- 6.3. Market Revenue, by Ownership (2017-2030)
- 6.4. Market Revenue, by End User (2017-2030)
- 6.5. Market Revenue, by Region (2017-2030)
Chapter 7. North America Market
- 7.1. Overview
- 7.2. Market Revenue, by Application (2017-2030)
- 7.3. Market Revenue, by Ownership (2017-2030)
- 7.4. Market Revenue, by End User (2017-2030)
- 7.5. Market Revenue, by Country (2017-2030)
Chapter 8. Europe Market
- 8.1. Overview
- 8.2. Market Revenue, by Application (2017-2030)
- 8.3. Market Revenue, by Ownership (2017-2030)
- 8.4. Market Revenue, by End User (2017-2030)
- 8.5. Market Revenue, by Country (2017-2030)
Chapter 9. APAC Market
- 9.1. Overview
- 9.2. Market Revenue, by Application (2017-2030)
- 9.3. Market Revenue, by Ownership (2017-2030)
- 9.4. Market Revenue, by End User (2017-2030)
- 9.5. Market Revenue, by Country (2017-2030)
Chapter 10. LATAM Market
- 10.1. Overview
- 10.2. Market Revenue, by Application (2017-2030)
- 10.3. Market Revenue, by Ownership (2017-2030)
- 10.4. Market Revenue, by End User (2017-2030)
- 10.5. Market Revenue, by Country (2017-2030)
Chapter 11. MEA Market
- 11.1. Overview
- 11.2. Market Revenue, by Application (2017-2030)
- 11.3. Market Revenue, by Ownership (2017-2030)
- 11.4. Market Revenue, by End User (2017-2030)
- 11.5. Market Revenue, by Country (2017-2030)
Chapter 12. U.S. Market
- 12.1. Overview
- 12.2. Market Revenue, by Application (2017-2030)
- 12.3. Market Revenue, by Ownership (2017-2030)
- 12.4. Market Revenue, by End User (2017-2030)
Chapter 13. Canada Market
- 13.1. Overview
- 13.2. Market Revenue, by Application (2017-2030)
- 13.3. Market Revenue, by Ownership (2017-2030)
- 13.4. Market Revenue, by End User (2017-2030)
Chapter 14. Germany Market
- 14.1. Overview
- 14.2. Market Revenue, by Application (2017-2030)
- 14.3. Market Revenue, by Ownership (2017-2030)
- 14.4. Market Revenue, by End User (2017-2030)
Chapter 15. France Market
- 15.1. Overview
- 15.2. Market Revenue, by Application (2017-2030)
- 15.3. Market Revenue, by Ownership (2017-2030)
- 15.4. Market Revenue, by End User (2017-2030)
Chapter 16. U.K. Market
- 16.1. Overview
- 16.2. Market Revenue, by Application (2017-2030)
- 16.3. Market Revenue, by Ownership (2017-2030)
- 16.4. Market Revenue, by End User (2017-2030)
Chapter 17. Italy Market
- 17.1. Overview
- 17.2. Market Revenue, by Application (2017-2030)
- 17.3. Market Revenue, by Ownership (2017-2030)
- 17.4. Market Revenue, by End User (2017-2030)
Chapter 18. Spain Market
- 18.1. Overview
- 18.2. Market Revenue, by Application (2017-2030)
- 18.3. Market Revenue, by Ownership (2017-2030)
- 18.4. Market Revenue, by End User (2017-2030)
Chapter 19. Japan Market
- 19.1. Overview
- 19.2. Market Revenue, by Application (2017-2030)
- 19.3. Market Revenue, by Ownership (2017-2030)
- 19.4. Market Revenue, by End User (2017-2030)
Chapter 20. China Market
- 20.1. Overview
- 20.2. Market Revenue, by Application (2017-2030)
- 20.3. Market Revenue, by Ownership (2017-2030)
- 20.4. Market Revenue, by End User (2017-2030)
Chapter 21. India Market
- 21.1. Overview
- 21.2. Market Revenue, by Application (2017-2030)
- 21.3. Market Revenue, by Ownership (2017-2030)
- 21.4. Market Revenue, by End User (2017-2030)
Chapter 22. Australia Market
- 22.1. Overview
- 22.2. Market Revenue, by Application (2017-2030)
- 22.3. Market Revenue, by Ownership (2017-2030)
- 22.4. Market Revenue, by End User (2017-2030)
Chapter 23. South Korea Market
- 23.1. Overview
- 23.2. Market Revenue, by Application (2017-2030)
- 23.3. Market Revenue, by Ownership (2017-2030)
- 23.4. Market Revenue, by End User (2017-2030)
Chapter 24. Brazil Market
- 24.1. Overview
- 24.2. Market Revenue, by Application (2017-2030)
- 24.3. Market Revenue, by Ownership (2017-2030)
- 24.4. Market Revenue, by End User (2017-2030)
Chapter 25. Mexico Market
- 25.1. Overview
- 25.2. Market Revenue, by Application (2017-2030)
- 25.3. Market Revenue, by Ownership (2017-2030)
- 25.4. Market Revenue, by End User (2017-2030)
Chapter 26. Saudi Arabia Market
- 26.1. Overview
- 26.2. Market Revenue, by Application (2017-2030)
- 26.3. Market Revenue, by Ownership (2017-2030)
- 26.4. Market Revenue, by End User (2017-2030)
Chapter 27. South Africa Market
- 27.1. Overview
- 27.2. Market Revenue, by Application (2017-2030)
- 27.3. Market Revenue, by Ownership (2017-2030)
- 27.4. Market Revenue, by End User (2017-2030)
Chapter 28. U.A.E. Market
- 28.1. Overview
- 28.2. Market Revenue, by Application (2017-2030)
- 28.3. Market Revenue, by Ownership (2017-2030)
- 28.4. Market Revenue, by End User (2017-2030)
Chapter 29. Competitive Landscape
- 29.1. List of Market Players and their Offerings
- 29.2. Competitive Benchmarking of Key Players
- 29.3. Product Benchmarking of Key Players
- 29.4. Recent Strategic Developments
Chapter 30. Company Profiles
- 30.1. Campbell Family Medicine
- 30.1.1. Business overview
- 30.1.2. Product and service offerings
- 30.1.3. Key financial summary
- 30.2. Castle Connolly Private Health Partners LLC
- 30.2.1. Business overview
- 30.2.2. Product and service offerings
- 30.2.3. Key financial summary
- 30.3. CONCIERGE CONSULTANTS & CARDIOLOGY
- 30.3.1. Business overview
- 30.3.2. Product and service offerings
- 30.3.3. Key financial summary
- 30.4. MDVIP LLC
- 30.4.1. Business overview
- 30.4.2. Product and service offerings
- 30.4.3. Key financial summary
- 30.5. PartnerMD
- 30.5.1. Business overview
- 30.5.2. Product and service offerings
- 30.5.3. Key financial summary
- 30.6. PENINSULA DOCTOR
- 30.6.1. Business overview
- 30.6.2. Product and service offerings
- 30.6.3. Key financial summary
- 30.7. Priority Physicians Inc.
- 30.7.1. Business overview
- 30.7.2. Product and service offerings
- 30.7.3. Key financial summary
- 30.8. SignatureMD Inc.
- 30.8.1. Business overview
- 30.8.2. Product and service offerings
- 30.8.3. Key financial summary
- 30.9. Specialdocs Consultants LLC
- 30.9.1. Business overview
- 30.9.2. Product and service offerings
- 30.9.3. Key financial summary
Chapter 31. Appendix
- 31.1. Abbreviations
- 31.2. Sources and References
- 31.3. Related Reports
